Glucocorticoids in Patients With IgG4-RD

Status Unknown status

Clinical Trial Summary

This is a randomized, open-label, single-center clinical trial to compare the efficacy and safety profile for medium-dose versus high dose glucocorticoid in patients with IgG4-related Disease. Patients will be followed for three months to measure the primary outcome and secondary outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

IgG4-related Disease

Clinical Trial Details

NCT number	NCT01758393
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Hua Chen, MD
Phone	+86-10-69158797
Email	chenhua@pumch.cn
Status	Unknown status
Phase	Phase 2/Phase 3
Start date	December 2012
Completion date	April 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03368274` - To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom	Phase 4
Not yet recruiting	`NCT03267875` - A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood	N/A
Completed	`NCT02616705` - Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Completed	`NCT03669861` - Safety and Efficacy of Abatacept in IgG4-Related Disease	Phase 2
Recruiting	`NCT05625581` - Tofatib Treatment for IgG4-related Disease
Recruiting	`NCT04125511` - Characterizing IgG4-RD With 68Ga-FAPI PET/CT	Early Phase 1
Not yet recruiting	`NCT06285539` - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases	Phase 2
Not yet recruiting	`NCT05746689` - Study of Sirolimus in IgG4-related Disease	N/A
Completed	`NCT03690908` - Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease
Completed	`NCT02899039` - Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease	N/A
Recruiting	`NCT04660565` - Belimumab Treatment for IgG4-related Disease	Phase 4
Recruiting	`NCT01670695` - A Prospective Cohort Study of IgG4RD in China	N/A
Recruiting	`NCT03023371` - National Registry of IgG4-RD in China	N/A
Completed	`NCT02705638` - Treatment of IgG4-Related Disease With Revlimid and Rituximab	Phase 1
Recruiting	`NCT03473912` - Meir Medical Center Rheumatologic Biobank
Not yet recruiting	`NCT03466970` - Plasmablast Detection From IgG4-Related Disease Patients	N/A